Skip to content
← Full study record

NCT03202628 · OUTCOME

Engraftment Kinetics (White Blood Cells [WBC] and Platelet) Following Single Salvage Autologous Stem Cell Transplantation (ASCT)

Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma · Source last updated 2023-09-21

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 3 years

What was measured

Will be measured by assessing the timing of recovery of bone marrow function. Will be summarized using descriptive statistics.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
Will be measured by assessing the timing of recovery of bone marrow function. Will be summarized using descriptive statistics.
reporting Status
NOT_POSTED
time Frame
Up to 3 years
title
Engraftment Kinetics (White Blood Cells [WBC] and Platelet) Following Single Salvage Autologous Stem Cell Transplantation (ASCT)
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice